BIRC5 and cancer: Some targets of miR-218, such as ROBO1, RICTOR, BIRC5 and LAMB3, have been reported to participate in many cancer signaling pathways, such as the ERK/MAPK, Wnt/β-catenin, and Notch pathways [12,41,42].